{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T06:58:15Z","timestamp":1781506695882,"version":"3.54.1"},"reference-count":16,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,5]]},"DOI":"10.1097\/inf.0b013e3182490a2c","type":"journal-article","created":{"date-parts":[[2012,1,6]],"date-time":"2012-01-06T14:31:35Z","timestamp":1325860295000},"page":"487-493","source":"Crossref","is-referenced-by-count":62,"title":["Safety, Reactogenicity and Immunogenicity of the Human Rotavirus Vaccine in Preterm European Infants"],"prefix":"10.1097","volume":"31","author":[{"given":"Felix","family":"Omenaca","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean","family":"Sarlangue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leszek","family":"Szenborn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Nogueira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pemmaraju V.","family":"Suryakiran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Igor V.","family":"Smolenov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Htay H.","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-14-20210202","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1542\/peds.2007-3378","article-title":"Active, population-based surveillance for severe rotavirus gastroenteritis in children in the United States.","volume":"122","author":"Payne","year":"2008","journal-title":"Pediatrics"},{"key":"R4-14-20210202","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/S0264-410X(97)00210-7","article-title":"Safety and immunogenicity of live, attenuated human rotavirus vaccine 89-12.","volume":"16","author":"Bernstein","year":"1998","journal-title":"Vaccine"},{"key":"R5-14-20210202","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1016\/S0140-6736(07)61744-9","article-title":"Efficacy of human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in European infants: randomised, double-blind controlled study.","volume":"370","author":"Vesikari","year":"2007","journal-title":"Lancet"},{"key":"R6-14-20210202","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa052434","article-title":"Human Rotavirus Vaccine Study GroupSafety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis.","volume":"354","author":"Ruiz-Palacios","year":"2006","journal-title":"N Engl J Med"},{"key":"R7-14-20210202","doi-asserted-by":"crossref","first-page":"5936","DOI":"10.1016\/j.vaccine.2009.07.098","article-title":"Safety and efficacy of human rotavirus vaccine during the first 2 years of life in Asian infants: randomised, double-blind, controlled study.","volume":"27","author":"Phua","year":"2009","journal-title":"Vaccine"},{"key":"R8-14-20210202","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1086\/649843","article-title":"Effectiveness of monovalent rotavirus vaccine (Rotarix) against severe diarrhea caused by serotypically unrelated G2P4 strains in Brazil.","volume":"201","author":"Correia","year":"2010","journal-title":"J Infect Dis"},{"key":"R9-14-20210202","doi-asserted-by":"crossref","first-page":"E3","DOI":"10.1542\/peds.103.1.e3","article-title":"Perinatal risk factors for infant hospitalization with viral gastroenteritis.","volume":"103","author":"Newman","year":"1999","journal-title":"Pediatrics"},{"key":"R10-14-20210202","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1001\/jama.282.6.547","article-title":"Immunization levels among premature and low-birth-weight infants and risk factors for delayed up-to-date immunization statusCenters for Disease Control and Prevention Vaccine Safety Datalink Group.","volume":"282","author":"Davis","year":"1999","journal-title":"JAMA"},{"key":"R11-14-20210202","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1001\/archpedi.155.2.167","article-title":"Delays in receipt of immunizations in low-birth-weight children: a nationally representative sample.","volume":"155","author":"Langkamp","year":"2001","journal-title":"Arch Pediatr Adolesc Med"},{"issue":"RR-2","key":"R13-14-20210202","first-page":"1","article-title":"Centers for Disease Control and Prevention (CDC)Prevention of rotavirus gastroenteritis among infants and children: recommendations of the Advisory Committee on Immunization Practices (ACIP).","volume":"58","author":"Cortese","year":"2009","journal-title":"MMWR Recomm Rep"},{"key":"R14-14-20210202","doi-asserted-by":"crossref","first-page":"2704","DOI":"10.1128\/JCM.00378-09","article-title":"Detection and genotyping of human rotavirus VP4 and VP7 genes by reverse transcriptase PCR and reverse hybridization.","volume":"47","author":"van Doorn","year":"2009","journal-title":"J Clin Microbiol"},{"key":"R15-14-20210202","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1097\/INF.0b013e31814521cb","article-title":"Safety and efficacy of the pentavalent human-bovine (WC3) reassortant rotavirus vaccine in healthy premature infants.","volume":"26","author":"Goveia","year":"2007","journal-title":"Pediatr Infect Dis J"},{"key":"R16-14-20210202","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1097\/INF.0b013e31819715fa","article-title":"The human rotavirus vaccine RIX4414 in infants: a review of safety and tolerability.","volume":"28","author":"Cheuvart","year":"2009","journal-title":"Pediatr Infect Dis J"},{"issue":"suppl 1","key":"R17-14-20210202","doi-asserted-by":"crossref","first-page":"S6","DOI":"10.1086\/431511","article-title":"Evaluation of RIX4414, a live, attenuated rotavirus vaccine, in a randomized, double-blind, placebo-controlled phase 2 trial involving 2464 Singaporean infants.","volume":"192","author":"Phua","year":"2005","journal-title":"J Infect Dis"},{"key":"R18-14-20210202","doi-asserted-by":"crossref","first-page":"5272","DOI":"10.1016\/j.vaccine.2010.05.057","article-title":"Immunogenicity and safety of the human rotavirus vaccine Rotarix co-administered with routine infant vaccines following the vaccination schedules in Europe.","volume":"28","author":"Vesikari","year":"2010","journal-title":"Vaccine"},{"key":"R20-14-20210202","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1136\/adc.2005.086306","article-title":"Immunisation of premature infants.","volume":"91","author":"Bonhoeffer","year":"2006","journal-title":"Arch Dis Child"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00006454-201205000-00014","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,10]],"date-time":"2021-04-10T06:01:40Z","timestamp":1618034500000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006454-201205000-00014"}},"subtitle":["A Randomized Phase IIIb Study"],"short-title":[],"issued":{"date-parts":[[2012,5]]},"references-count":16,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0b013e3182490a2c","relation":{},"ISSN":["0891-3668"],"issn-type":[{"value":"0891-3668","type":"print"}],"subject":[],"published":{"date-parts":[[2012,5]]}}}